FDA will remove long-standing warning from hormone-based menopause drugs, citing benefits for women
Lead The Food and Drug Administration announced Monday it will remove the 22-year-old boxed warning from more than 20 estrogen- and progestin-containing pills, patches and creams used to treat menopause symptoms such as hot flashes and night sweats. Officials said new analyses show lower cardiovascular and cognitive risks when hormone therapy is begun before age … Read more